Overview

An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Open-label comparison of standard 12-week regimen of varenicline with standard 10-week regimen of transdermal nicotine patch for smoking cessation.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Nicotine
Varenicline